WORCESTER, Mass., July 10, 2008 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, is scheduled to make a poster presentation of clinical data at the 35th Annual Meeting & Exposition of the Controlled Release Society (www.controlledrelease.org) in New York, July 12 - 16, 2008.
